Chantal Miklosi

Chantal Miklosi is the current CFO at Optina Diagnostics. Chantal has also served as a board member at E2IP Technologies and as the Chief Financial Officer at Esperas Pharma Inc., Optina Diagnostics, Vespina Lifesciences Inc., H2Biologics Inc., and H2 Biopharma. Miklosi began their career in finance as a Senior Financial Analysis Manager at Orrick, Herrington & Sutcliffe. Chantal then became a Senior Director of Financial Planning and Analysis at Versata before moving into investment banking as an Associate at Nationsbanc Montgomery Securities and Thomas Weisel Partners.

Chantal Miklosi has an MBA from The University of Western Ontario - Richard Ivey School of Business and a BAA from HEC Montréal.

Their manager is David Lapointe, President & CEO. Chantal Miklosi works with Jean-Philippe Sylvestre - CTO, George Mallin - Product Manager, and Shannon Campbell - VP, Clinical & Medical Affairs.